Literature DB >> 32855220

Serum mitochondrial DNA predicts the risk of acute exacerbation and progression of idiopathic pulmonary fibrosis.

Koji Sakamoto1,2, Taiki Furukawa3,2, Yasuhiko Yamano4, Kensuke Kataoka4, Ryo Teramachi5, Anjali Walia6, Atsushi Suzuki5, Masahide Inoue5, Yoshio Nakahara5, Changwan Ryu6, Naozumi Hashimoto5, Yasuhiro Kondoh4.   

Abstract

Entities:  

Year:  2021        PMID: 32855220      PMCID: PMC8177039          DOI: 10.1183/13993003.01346-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  10 in total

1.  Competing risk analysis using R: an easy guide for clinicians.

Authors:  L Scrucca; A Santucci; F Aversa
Journal:  Bone Marrow Transplant       Date:  2007-06-11       Impact factor: 5.483

2.  Extracellular Mitochondrial DNA Is Generated by Fibroblasts and Predicts Death in Idiopathic Pulmonary Fibrosis.

Authors:  Changwan Ryu; Huanxing Sun; Mridu Gulati; Jose D Herazo-Maya; Yonglin Chen; Awo Osafo-Addo; Caitlin Brandsdorfer; Julia Winkler; Christina Blaul; Jaden Faunce; Hongyi Pan; Tony Woolard; Argyrios Tzouvelekis; Danielle E Antin-Ozerkis; Jonathan T Puchalski; Martin Slade; Anjelica L Gonzalez; Daniel F Bogenhagen; Varvara Kirillov; Carol Feghali-Bostwick; Kevin Gibson; Kathleen Lindell; Raimund I Herzog; Charles S Dela Cruz; Wajahat Mehal; Naftali Kaminski; Erica L Herzog; Glenda Trujillo
Journal:  Am J Respir Crit Care Med       Date:  2017-12-15       Impact factor: 21.405

Review 3.  Clinical course and prediction of survival in idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Harold R Collard; Talmadge E King
Journal:  Am J Respir Crit Care Med       Date:  2010-10-08       Impact factor: 21.405

4.  TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis.

Authors:  Glenda Trujillo; Alessia Meneghin; Kevin R Flaherty; Lynette M Sholl; Jeffrey L Myers; Ella A Kazerooni; Barry H Gross; Sameer R Oak; Ana Lucia Coelho; Holly Evanoff; Elizabeth Day; Galen B Toews; Amrita D Joshi; Matthew A Schaller; Beatrice Waters; Gabor Jarai; John Westwick; Steven L Kunkel; Fernando J Martinez; Cory M Hogaboam
Journal:  Sci Transl Med       Date:  2010-11-10       Impact factor: 17.956

5.  Predictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis.

Authors:  Brett Ley; Williamson Z Bradford; Eric Vittinghoff; Derek Weycker; Roland M du Bois; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2016-09-15       Impact factor: 21.405

Review 6.  Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.

Authors:  Harold R Collard; Christopher J Ryerson; Tamera J Corte; Gisli Jenkins; Yasuhiro Kondoh; David J Lederer; Joyce S Lee; Toby M Maher; Athol U Wells; Katerina M Antoniou; Juergen Behr; Kevin K Brown; Vincent Cottin; Kevin R Flaherty; Junya Fukuoka; David M Hansell; Takeshi Johkoh; Naftali Kaminski; Dong Soon Kim; Martin Kolb; David A Lynch; Jeffrey L Myers; Ganesh Raghu; Luca Richeldi; Hiroyuki Taniguchi; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2016-08-01       Impact factor: 21.405

7.  A multidimensional index and staging system for idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Christopher J Ryerson; Eric Vittinghoff; Jay H Ryu; Sara Tomassetti; Joyce S Lee; Venerino Poletti; Matteo Buccioli; Brett M Elicker; Kirk D Jones; Talmadge E King; Harold R Collard
Journal:  Ann Intern Med       Date:  2012-05-15       Impact factor: 25.391

8.  Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation.

Authors:  Kiichi Nakahira; Sun-Young Kyung; Angela J Rogers; Lee Gazourian; Sojung Youn; Anthony F Massaro; Carolina Quintana; Juan C Osorio; Zhaoxi Wang; Yang Zhao; Laurie A Lawler; Jason D Christie; Nuala J Meyer; Finnian R Mc Causland; Sushrut S Waikar; Aaron B Waxman; Raymond T Chung; Raphael Bueno; Ivan O Rosas; Laura E Fredenburgh; Rebecca M Baron; David C Christiani; Gary M Hunninghake; Augustine M K Choi
Journal:  PLoS Med       Date:  2013-12-31       Impact factor: 11.069

9.  Stimulator of Interferon Genes Deficiency in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.

Authors:  Hui Qiu; Dong Weng; Tao Chen; Li Shen; Shan-Shan Chen; Ya-Ru Wei; Qin Wu; Meng-Meng Zhao; Qiu-Hong Li; Yang Hu; Yuan Zhang; Ying Zhou; Yi-Liang Su; Fen Zhang; Li-Qin Lu; Nian-Yu Zhou; Sen-Lin Li; Le-Le Zhang; Chen Wang; Hui-Ping Li
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

10.  Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Jeffrey L Myers; Luca Richeldi; Christopher J Ryerson; David J Lederer; Juergen Behr; Vincent Cottin; Sonye K Danoff; Ferran Morell; Kevin R Flaherty; Athol Wells; Fernando J Martinez; Arata Azuma; Thomas J Bice; Demosthenes Bouros; Kevin K Brown; Harold R Collard; Abhijit Duggal; Liam Galvin; Yoshikazu Inoue; R Gisli Jenkins; Takeshi Johkoh; Ella A Kazerooni; Masanori Kitaichi; Shandra L Knight; George Mansour; Andrew G Nicholson; Sudhakar N J Pipavath; Ivette Buendía-Roldán; Moisés Selman; William D Travis; Simon Walsh; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2018-09-01       Impact factor: 21.405

  10 in total
  3 in total

Review 1.  Evolving Perspectives on Innate Immune Mechanisms of IPF.

Authors:  Genta Ishikawa; Angela Liu; Erica L Herzog
Journal:  Front Mol Biosci       Date:  2021-08-09

2.  Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis.

Authors:  Corina N D'Alessandro-Gabazza; Taro Yasuma; Tetsu Kobayashi; Masaaki Toda; Ahmed M Abdel-Hamid; Hajime Fujimoto; Osamu Hataji; Hiroki Nakahara; Atsuro Takeshita; Kota Nishihama; Tomohito Okano; Haruko Saiki; Yuko Okano; Atsushi Tomaru; Valeria Fridman D'Alessandro; Miyako Shiraishi; Akira Mizoguchi; Ryoichi Ono; Junpei Ohtsuka; Masayuki Fukumura; Tetsuya Nosaka; Xuenan Mi; Diwakar Shukla; Kensuke Kataoka; Yasuhiro Kondoh; Masaki Hirose; Toru Arai; Yoshikazu Inoue; Yutaka Yano; Roderick I Mackie; Isaac Cann; Esteban C Gabazza
Journal:  Nat Commun       Date:  2022-03-23       Impact factor: 14.919

Review 3.  Biomarkers in Progressive Fibrosing Interstitial Lung Disease: Optimizing Diagnosis, Prognosis, and Treatment Response.

Authors:  Willis S Bowman; Gabrielle A Echt; Justin M Oldham
Journal:  Front Med (Lausanne)       Date:  2021-05-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.